LMR Partners LLP Has $1,088,000 Stake in CME Group Inc. (CME)
LMR Partners LLP decreased its stake in CME Group Inc. (NASDAQ:CME) by 46.9% during the second quarter, Holdings Channel reports. The institutional investor owned 11,168 shares of the company’s stock after selling 9,871 shares during the period. LMR Partners LLP’s holdings in CME Group were worth $1,088,000 as of its most recent SEC filing.
Other institutional investors have also bought and sold shares of the company. Parametrica Management Ltd purchased a new position in CME Group during the second quarter valued at approximately $212,000. Franklin Resources Inc. purchased a new position in CME Group during the first quarter valued at approximately $222,000. Financial Architects Inc purchased a new position in CME Group during the second quarter valued at approximately $234,000. EFG Asset Management Americas Corp. purchased a new position in CME Group during the first quarter valued at approximately $244,000. Finally, Windward Capital Management Co. CA boosted its position in CME Group by 1.0% in the second quarter. Windward Capital Management Co. CA now owns 2,626 shares of the company’s stock valued at $256,000 after buying an additional 25 shares during the period. 80.29% of the stock is owned by institutional investors and hedge funds.
CME Group Inc. (NASDAQ:CME) traded down 0.36% on Friday, hitting $103.82. The stock had a trading volume of 844,120 shares. The company’s 50 day moving average is $106.70 and its 200-day moving average is $99.42. CME Group Inc. has a 1-year low of $81.87 and a 1-year high of $110.35. The firm has a market capitalization of $35.18 billion, a price-to-earnings ratio of 26.22 and a beta of 0.83.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, July 28th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The company had revenue of $906 million for the quarter, compared to analysts’ expectations of $897.84 million. During the same quarter in the previous year, the firm posted $0.95 earnings per share. CME Group’s revenue for the quarter was up 10.5% on a year-over-year basis. On average, analysts forecast that CME Group Inc. will post $4.43 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.40 dividend on an annualized basis and a yield of 2.31%. CME Group’s dividend payout ratio (DPR) is currently 60.61%.
A number of equities analysts have recently issued reports on the company. Jefferies Group increased their target price on CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a report on Wednesday, August 31st. Deutsche Bank AG increased their target price on CME Group from $115.00 to $116.00 and gave the stock a “buy” rating in a report on Wednesday. JPMorgan Chase & Co. set a $116.00 target price on CME Group and gave the stock a “buy” rating in a report on Monday, September 12th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a report on Thursday, June 30th. Finally, Barclays PLC dropped their target price on CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a report on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the stock. CME Group has an average rating of “Hold” and a consensus price target of $103.27.
In other news, insider Bryan T. Durkin sold 15,000 shares of the company’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $107.75, for a total transaction of $1,616,250.00. Following the transaction, the insider now owns 63,967 shares in the company, valued at $6,892,444.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Hilda Harris Piell sold 893 shares of the company’s stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $110.00, for a total transaction of $98,230.00. Following the transaction, the insider now owns 29,125 shares in the company, valued at approximately $3,203,750. The disclosure for this sale can be found here. Company insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.